Sort
89,613 grants matching “depression”
Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities
$2,918,686Tallie Z. Z Baram · University Of California-Irvine · P50 · FY2023 · MH
MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS
$2,917,850Neelum T Aggarwal · Rush University Medical Center · R01 · FY2025 · AG
Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health
$2,917,667Paige L Williams · Harvard School Of Public Health · R01 · FY2023 · HD
Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders
$2,917,074Gretchen L Snyder · Intra-Cellular Therapies, Inc. · UG3 · FY2021 · DA
Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System
$2,912,944Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Evidence-Informed Mental health Prevention, Assessment, Collaboration, and Treatment in Middle Schools (E-IMPACTS)
$2,910,771Michael D Lyons · University Of Virginia · RF1 · FY2022 · MH
Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities
$2,909,986Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2024 · DA
The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19
$2,908,756Katherine Laurel Possin · University Of California, San Francisco · R01 · FY2022 · AG
Mild Cognitive Impairment: A Prospective Community Study
$2,906,516Mary Ganguli · University Of Pittsburgh At Pittsburgh · R37 · FY2022 · AG
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
$2,906,437Leah Helane Rubin · Johns Hopkins University · RF1 · FY2023 · MH
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
$2,902,630Kimford J Meador · Stanford University · U01 · FY2019 · NS
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age
$2,900,790Maria Luisa Alcaide · University Of Miami School Of Medicine · R01 · FY2019 · HD
Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans
$2,899,817Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · AG
Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities
$2,898,488Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2020 · DA
Section on Light and Circadian Rhythms
$2,897,708Samer Hattar · National Institute Of Mental Health · ZIA · FY2019 · MH
Risk Factors in Childhood-Onset Depression
$2,896,813Maria Kovacs · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · MH
Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
$2,884,653Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2023 · DA
Investigating Mechanisms of Intra- and Inter-individual Pain Variability in Patients with Comorbid Chronic Pain and Depression
$2,884,008Matthew Herbert · University Of California, San Diego · R01 · FY2025 · AR
Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patients
$2,883,251David M Charytan · New York University School Of Medicine · U01 · FY2019 · DK
Los Angeles Latino Eye Study
$2,882,384University Of Southern California · U10 · FY2004 · EY
Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort
$2,882,247Alan M Jacobson · Nyu Winthrop Hospital · DP3 · FY2017 · DK
Mild Cognitive Impairment: A Prospective Community Study
$2,882,221Mary Ganguli · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · AG
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,882,001Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2025 · HL
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,881,939Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2025 · DA
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS
$2,881,761Emory University · P50 · FY2003 · MH